Clinical Trend of the Week (January 6-12): Scleroderma
The findings from a clinical trial that examined a new therapeutic regimen for a life-threatening autoimmune disease resulted in this week’s top search term. The study investigated the effect of myeloablative autologous hematopoietic stem cell transplant (HSCT) on patients with severe scleroderma. The results showed that the regimen, which includes chemotherapy and total body radiation, improved survival and quality of life for people with the condition. In fact, the study found that HSCT was superior to treatment with cyclophosphamide, an immune-suppressing drug. Because diffuse systemic sclerosis is often fatal, new potential treatment options are sure to capture the interest of healthcare professionals treating those with the condition.
For more information on scleroderma, read here.
Medscape © 2018
Cite this: Ryan Syrek. Trending Clinical Topics for January 2018 - Medscape - Jan 26, 2018.